A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late.  The MPP-brokered sublicences follow on from an agreement between […] Continue reading ->
The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday.  The  announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading ->
Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics.  The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs).  In comparison […] Continue reading ->
Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are  struggling roll out efficiently.  Reflections on the first anniversary of the massive COVAX vaccine rollout.  On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading ->
ISLAMABAD – The timing couldn’t have been worse.  On the same day that Bill Gates, completed his maiden visit to Pakistan to cheer on the country’s progress towards polio eradication, WHO and Malawi health authorities announced that a small child thousands of kilometers away in Malawi had been ill with polio – infected by a […] Continue reading ->
Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading ->
South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading ->
European Union President Charles Michel congratulated African countries for their efforts to stimulate more vaccine manufacturing capacity on the continent, in a upbeat opening address at the European Union-African Union Summit, which began Thursday.   But in a more sobering note Wednesday, Stella Kyriakides, the European Commissioner for Health and Food Safety, called on global health […] Continue reading ->
The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well.  South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading ->